Uchihara N, Tamaki N, Marusawa H, Urawa N, et al. Efficacy of Lenvatinib as Subsequent Therapy After Combination Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma. Anticancer Res 2026;46:4443-4452.
PMID: 42527085